Effect of inactivated vaccine on H9N2 transmission and evolution in chickens
05.04.2025
npj Vaccines | ( 2025) 10:67
H9N2 avian influenza virus (AIV) is a low-pathogenicity virus endemic in poultry populations across Asia, the Middle East, and parts of Africa, with sporadic detection in the Americas and Europe. Despite its relatively mild clinical presentation in chickens, H9N2 AIV has significant economic consequences due to decreased productivity and increased susceptibility to secondary infections. Moreover, the virus possesses zoonotic potential, with documented transmission to mammals, including humans. Its internal gene segments have contributed to the emergence of several human-infecting avian influenza viruses (e.g., H5N6, H7N9).
A recent study published in Nature investigates the effects of inactivated H9N2 vaccines on viral replication, transmission, genetic evolution, and cross-species adaptation potential, using both in vivo transmission models and deep sequencing approaches. It also evaluates alternative vaccination strategies capable of inducing broader immune responses.
Read more